An induced pluripotent stem cell line (MUSIi019-A) generated from a patient with distal renal tubular acidosis carrying a compound heterozygous mutation in solute carrier family 4 member 1 (SLC4A1) gene

被引：0

作者：

Kaewboonlert, Narissara ^{[1
,2
]}

Wattanapanitch, Methichit ^{[3
]}

Praditsap, Oranud ^{[4
]}

Deejai, Nipaporn ^{[1
]}

Chanprasert, Chutima ^{[5
]}

Sawasdee, Nunghathai ^{[1
]}

Nettuwakul, Choochai ^{[1
]}

Wanachiwanawin, Wanchai ^{[6
]}

Sritippayawan, Suchai ^{[7
]}

Thamtarana, Prapaporn Jungtrakoon ^{[5
]}

Yenchitsomanus, Pa-thai ^{[1
]}

Rungroj, Nanyawan ^{[4
]}

机构：

[1] Mahidol Univ, Fac Med, Siriraj Hosp, Div Mol Med,Res Dept, Bangkok, Thailand

[2] Mahidol Univ, Fac Med, Siriraj Hosp, Biomed Sci Program, Bangkok, Thailand

[3] Mahidol Univ, Siriraj Ctr Regenerat Med, Res Dept, Fac Med,Siriraj Hosp, Bangkok, Thailand

[4] Mahidol Univ, Fac Med, Siriraj Hosp, Siriraj Genom, Bangkok, Thailand

[5] Mahidol Univ, Cellular & Mol Biol Diabet Res Grp, Siriraj Hosp, Div Mol Med,Res Dept,Fac Med, Bangkok, Thailand

[6] Mahidol Univ, Fac Med, Siriraj Hosp, Div Hematol,Dept Med, Bangkok, Thailand

[7] Mahidol Univ, Fac Med, Siriraj Hosp, Div Nephrol,Dept Med, Bangkok, Thailand

来源：

STEM CELL RESEARCH | 2023年 / 67卷

关键词：

Distal renal tubular acidosis; Hemolytic anemia; iPSC; SAO;

D O I：

10.1016/j.scr.2023.103043

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

Distal renal tubular acidosis (dRTA), a disease characterized by the failure of the distal nephron to secrete acid into the urine, can be caused by mutations in SLC4A1 gene encoding erythroid and kidney anion exchanger 1 (AE1). Here, an induced pluripotent stem cell (iPSC) line was generated from a patient with dRTA and hemolytic anemia carrying compound heterozygous SLC4A1 mutations containing c.1199_1225del (p.Ala400_Ala408del), resulting in Southeast Asian ovalocytosis (SAO), and c.1331C>A (p.Thr444Asn). Peripheral blood mononuclear cells (PBMCs) were reprogrammed using Sendai viral reprogramming. The established iPSC line, MUSIi019-A, exhibited pluripotent property and retained the same mutations observed in the patients.

引用

页数：5

共 50 条

[41] Generation of a human induced pluripotent stem cell line (CRICKi021-A) from a patient with Ullrich congenital muscular dystrophy carrying a pathogenic mutation in the COL6A1 gene
Jiang, Yunsong
Devito, Liani G.
Muntoni, Francesco
Healy, Lyn
Tedesco, Francesco Saverio
STEM CELL RESEARCH, 2025, 83
[42] Establishment of an induced pluripotent stem cell line (FDEENTi002-A) from a patient with Best's disease carrying c.888C > A mutation in BEST1 gene
Bai, Xinyue
Yang, Xian-Jie
Chen, Ling
STEM CELL RESEARCH, 2019, 38
[43] Generation of an induced pluripotent stem cell line from a patient with global development delay carrying DYRK1A mutation (c.1730T>A) and a gene correction isogenic iPSC line
Ma, Ling
Wu, Ziyan
Tang, Qingyuan
Ji, Xiaoli
Mei, Yuting
Peng, Ting
Xu, Qiong
Zhou, Wenhao
Xiong, Man
STEM CELL RESEARCH, 2021, 53
[44] Generation of an induced pluripotent stem cell line (TRNDi002-B) from a patient carrying compound heterozygous p.Q208X and p.G310G mutations in the NGLY1 gene
Li, Rong
Pradhan, Manisha
Xu, Miao
Baskfield, Amanda
Farkhondeh, Atena
Cheng, Yu-Shan
Beers, Jeanette
Zou, Jizhong
Liu, Chengyu
Might, Matthew
Rodems, Steven
Zheng, Wei
STEM CELL RESEARCH, 2019, 34
[45] Generation of human induced pluripotent stem cell (hiPSC) line UOMi001-A from a patient with Leigh-like syndrome harbouring compound heterozygous variants in ECHS1 gene
Sequiera, Glen Lester
Rockman-Greenberg, Cheryl
Dhingra, Sanjiv
STEM CELL RESEARCH, 2020, 48
[46] Generation of an Alagille syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi032-A) carrying a heterozygous mutation (p.Cys682Leufs*7) in the JAG1 gene
Hatim, Omer
Pavlinov, Ivan
Xu, Miao
Linask, Kaari
Beers, Jeanette
Liu, Chengyu
Baumgartel, Karsten
Gilbert, Melissa
Spinner, Nancy
Chen, Catherine
Zou, Jizhong
Zheng, Wei
STEM CELL RESEARCH, 2023, 73
[47] Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene
D'Anzi, Angela
Altieri, Filomena
Perciballi, Elisa
Ferrari, Daniela
Bernardini, Laura
Goldoni, Marina
Mazzini, Letizia
De Marchi, Fabiola
Di Pierro, Alice
D'Alfonso, Sandra
Gelati, Maurizio
Vescovi, Angelo Luigi
Rosati, Jessica
STEM CELL RESEARCH, 2020, 47
[48] Generation and characterization of PBMCs-derived human induced pluripotent stem cell (iPSC) line SDQLCHi055-A from a patient with NEDSDV carrying a heterozygote mutation in the CTNNB1 gene
Yang, Yanan
Liu, Chen
Liu, Ning
Yang, Xiaomeng
Liu, Yi
Gai, Zhongtao
STEM CELL RESEARCH, 2024, 76
[49] Single A generation of human induced pluripotent stem cell line (MUi031-A) from a type-3 Gaucher disease patient carrying homozygous mutation on GBA1 gene
Pornsukjantra, Tanapat
Kangboonruang, Kitsada
Tong-Ngam, Pirut
Tim-Aroon, Thipwimol
Wattanasirichaigoon, Duangrurdee
Anurathapan, Usanarat
Hongeng, Suradej
Tubsuwan, Alisa
Bhukhai, Kanit
Asavapanumas, Nithi
STEM CELL RESEARCH, 2022, 60
[50] Establishment of CSUASOi001-A, a non-integrated induced pluripotent stem cell line from urine-derived cells of a Chinese patient carrying RS1 gene mutation
Yan, Xin
Guo, Yonglong
Chen, Juan
Cui, Zekai
Gu, Jianing
Wang, Yini
Mao, Shengru
Ding, Chengcheng
Chen, Jiansu
Tang, Shibo
STEM CELL RESEARCH, 2019, 38

← 1 2 3 4 5 →